title: Oral ketamine: a promising treatment for restless legs syndrome.
abstract: Oral Ketamine, an NMDA receptor antagonist, can be used to treat restless legs syndrome. A mechanism for the efficacy of this treatment is discussed.
authors.affiliation: Department of Anesthesiology, Temple University Hospital, Philadelphia, Pennsylvania, USA.
authors.forename: Neeraj
authors.initials: N
authors.lastname: Kapur
authors.forename: Robert
authors.initials: R
authors.lastname: Friedman
mesh_terms: D000284:Administration, Oral; D000368:Aged; D001416:Back Pain / Q000150:complications; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007383:Intermittent Claudication / Q000150:complications; D007649:Ketamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D012148:Restless Legs Syndrome / Q000150:complications / Q000188:drug therapy*
chemical_list: D018691:Excitatory Amino Acid Antagonists; D007649:Ketamine